A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.

Kalari, Mohadeseh; Abbasi, Zeinab; Shasaltaneh, Marzieh Dehghan; Khaleghian, Ali; Moosavi-Nejad, Zahra

Kalari, Mohadeseh; Abbasi, Zeinab; Shasaltaneh, Marzieh Dehghan; Khaleghian, Ali; Moosavi-Nejad, Zahra.

Afiliación

Kalari M; Department of Biochemistry, Semnan University of Medical Sciences, Semnan, Iran.
Abbasi Z; Department of Inorganic Chemistry Semnan University, Semnan, Iran.
Shasaltaneh MD; Department of Biology, Faculty of Science, University of Zanjan, Zanjan, Iran.
Khaleghian A; Department of Biochemistry, Semnan University of Medical Sciences, Semnan, Iran.
Moosavi-Nejad Z; Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.

J Alzheimers Dis ; 87(4): 1503-1516, 2022.

Article en En | MEDLINE | ID: mdl-35527546

Asunto(s)

Enfermedad de Alzheimer; Galantamina; Acetilcolinesterasa/metabolismo; Enfermedad de Alzheimer/tratamiento farmacológico; Inhibidores de la Colinesterasa/química; Inhibidores de la Colinesterasa/farmacología; Inhibidores de la Colinesterasa/uso terapéutico; Cobalto/farmacología; Cobalto/uso terapéutico; Galantamina/farmacología; Galantamina/uso terapéutico; Humanos; Simulación del Acoplamiento Molecular

Palabras clave

Acetylcholinesterase; Alzheimer's disease; enzyme kinetics; galantamine; inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Galantamina Límite: Humans Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google